Safety of 68 GaGa‐FAPI‐46 PET/CT including hemodynamic measurements and patient‐reported outcomes in cancer patients

Key Points

• To evaluate the safety and tolerability of [68Ga]Ga-FAPI-46 PET/CT in cancer patients, focusing on hemodynamic parameters and patient feedback.
• Conducted PET/CT scans using [68Ga]Ga-FAPI-46 in cancer patients
• Monitored hemodynamic measurements pre- and post-scan
• Collected patient-reported outcomes regarding discomfort
• No immediate patient-reported discomfort was observed following the scans
• Clinically relevant hemodynamic adverse events (AEs) were absent
• A decrease in heart rate from baseline to post-scan likely indicated pre-scan nervousness